Christopher Bissonette
Chris is Managing Partner of Pallasite Ventures, a seed venture capital fund founded in 2014 to enable the positive impact of breakthrough science at scale. To date, Pallasite has invested over $30M USD in 60 companies across the US and Canada. After evaluating the potential global impact of Ionomr’s technology and recognizing the passion and intellect of the Company’s science team, Pallasite led and co-led Ionomr’s three seed funding rounds and joined Ionomr’s board. Prior to Pallasite, Chris spent ten years as a research scientist focusing on stem cell treatments for Alzheimer’s disease, successfully launched a startup company. Subsequently, he spent several years in corporate finance and venture capital.